Number of the records: 1
sirolimus
SYS d020123 LBL 00000cz--a2200000n--4500 005 20250606213721.8 008 980611|||anznnbabn-----------|-a|a------ 040 $b slo $a DNLM $d BA006 $d BA006 065 $a D02.540.505.760 066 $a 01 $c 03 150 $a sirolimus $x AA $x AD $x AE $x AG $x AI $x AN $x BL $x CF $x CH $x CL $x CS $x EC $x HI $x IM $x IP $x ME $x PD $x PK $x PO $x RE $x SD $x ST $x TO $x TU $x UR $2 slo 450 $w v $a rapamycín $2 slo 450 $w v $a AY 22-989 $2 slo 450 $w v $a I-2190A $2 slo 450 $w v $a rapamun $2 slo 550 $7 sllk_us_auth*d000900 $Y Anti-Bacterial Agents $w P $a antibiotiká 550 $7 sllk_us_auth*d000903 $Y Antibiotics, Antineoplastic $w P $a antibiotiká protinádorové 550 $7 sllk_us_auth*d000935 $Y Antifungal Agents $w P $a antimykotiká 550 $7 sllk_us_auth*d007166 $Y Immunosuppressive Agents $w P $a imunosupresíva 665 $a 1999; use SIROLIMUS (NM) 1980-1997 $2 eng 665 $a Polyenes (1976-1998) $2 eng 680 9-
$i A macrolide compound obtained from Streptomyces hygroscopicus that acts by selectively blocking the transcriptional activation of cytokines thereby inhibiting cytokine production. It is bioactive only when bound to IMMUNOPHILINS. Sirolimus is a potent immunosuppressant and possesses both antifungal and antineoplastic properties. $2 eng 750 -2
$a Sirolimus $2 eng 980 $x M
Number of the records: 1